NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said first-quarter revenues increased nearly 240 percent as R&D spending rose 55 percent and profit jumped 200 on combined sales and spending stemming from the merger of Thermo Electron and Fisher Scientific.

 

Total receipts for the three months ended March 31 increased to $2.3 billion from $684.3 million year over year.